SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-073941
Filing Date
2024-03-21
Accepted
2024-03-21 16:52:57
Documents
6
Period of Report
2024-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d780936ddef14a.htm DEF 14A 343523
2 GRAPHIC g780936dsp001.jpg GRAPHIC 203080
3 GRAPHIC g780936dsp002.jpg GRAPHIC 172235
4 GRAPHIC g780936g53j94.jpg GRAPHIC 29701
5 GRAPHIC g780936g54l91.jpg GRAPHIC 30465
6 GRAPHIC g780936g82c09.jpg GRAPHIC 28236
  Complete submission text file 0001193125-24-073941.txt   970622
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35409 | Film No.: 24772060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)